Home » Newsletters » The Carlat Psychiatry Report

The Carlat Psychiatry Report

ADHD (February) | 2012

View Archived Issues

Are Clinical Scales Useful for Adult ADHD?

February 1, 2012

Patients often come into my office to be “tested for ADHD,” and I explain to them that the diagnosis depends on a thorough clinical interview. Nonetheless, rating scales can be useful. Read More

A Boatload of New Data on Stimulants and Cardiac Events

February 1, 2012

Daniel Carlat, MD

In 2006, an FDA panel recommended all manufacturers of stimulants to add a “black box” warning about an increased risk of “serious cardiovascular events.” Read More

Diagnosis and Treatment of ADHD in Adults

February 1, 2012

Aashish Parikh, MD

To begin with, you have to specify whether you are thinking in terms of DSM-IV criteria or probable DSM-5 criteria. The major difference is that currently you have to establish that ADHD symptoms began before age seven, whereas DSM-5 is more lenient, requiring that they began by age 12. Read More

Is Pharmacogenetic Testing Used—and Useful—in Clinical Practice?

February 1, 2012

Glen Spielmans, PhD

For years, we have read articles about the promise of pharmacogenetic testing to help us choose and monitor medication treatment. Read More

How Risky is Pregnancy for Women with a History of Mood Disorders?

February 1, 2012

Glen Spielmans, PhD

We know that the postpartum period is a risky time for women who have a history of depression, especially if they experienced postpartum depression in the past. But several questions about mood and pregnancy are still unanswered. Read More

FDA Publishes Article Critical of Vilazodone Data

February 1, 2012

Glen Spielmans, PhD

It has been over a year now since the approval of vilazodone (Viibryd). As you may recall from our review of the drug in TCPR April 2011, vilazodone is an SSRI with partial agonism at the 5HT1A receptor. Read More

Learning Objectives, ADHD, TCPR, February 2012

February 1, 2012

After reading these articles, you should be able to… Read More

Medication Fact Book for Psychiatric Practice, Seventh Edition (2024)
The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

General Psychiatry
Psychopharm Secrets: What Patients Won’t Tell You
How to assess med response when the patient reports is a poor guide: long-term mood stabilizers, sleep meds, and rapid cycling.
Listen now